Topics
- #Quality (3)
- ACCURUN (1)
- AMR (1)
- anti-fluor (1)
- Antigens & Antibodies (12)
- Beginners (2)
- biochemistry (1)
- BKV (1)
- BRCA (1)
- Calibration Verification (7)
- cancer (1)
- Carrier Screening (1)
- Case Study (1)
- CLIA (3)
- clinical genomics (8)
- Clinical Significance (1)
- CMV (2)
- CNV (1)
- Coronavirus (1)
- COVID-19 (2)
- ctDNA (1)
- Dengue Virus (1)
- Diagnostic Errors (2)
- DPYD (1)
- EBV (1)
- Flaviviruses (1)
- Genomic Testing (1)
- Hendra (1)
- HEV (1)
- HIV (1)
- HRD (1)
- Immuno-Oncology (1)
- Influenza (3)
- Inherited (1)
- ISO 15189 (2)
- IVD (1)
- KPL (1)
- Laboratory Challenges (2)
- liquid biopsy (1)
- lymphoma (1)
- Methylated DNA (3)
- Molecular Diagnostics (14)
- Mpox (1)
- NGS (12)
- Nipah (1)
- NIPT (2)
- PGT-A (1)
- Pharmacogenetics (1)
- proficiency testing (1)
- prostate (1)
- QC Challenges (2)
- QC Procedures (2)
- QC Regulation (2)
- Quality Control (7)
- Reagent Components (1)
- Reportable Range (1)
- Reproductive Health (1)
- Respiratory (1)
- Rhinovirus (1)
- RSV (1)
- SARS-CoV-2 (1)
- Serology (2)
- sexually transmitted diseases (1)
- STD (1)
- Tick-Borne Disease (2)
- TORCH (1)
- transplant (2)
- troubleshooting (1)
- VALIDATE (1)
- VLP (1)
- Webinar (1)
- Whooping Cough (1)
Subscribe to this blog by filling out the form below!
Posts about
NGS
Webinar Overview: Challenges of Liquid Biopsy Assay Validation and Quality Control
Liquid biopsy testing has been widely adopted to support early cancer diagnosis, therapy selection,...
5 minute read
Is ctDNA the Secret to Noninvasive Detection & Treatment of Lymphoma?
Nearly 5% of all cancer diagnoses in the U.S. are lymphoma. This cancer of the lymphatic system...
2 minute read
Biofidelity Customer Case Study
Premium reference materials help take innovative genomic technology into the clinic Biofidelityis...Ideal Samples for Validating Next-Generation Sequencing-Based Plasma Circulating Tumor DNA Assays
Over the past decade, liquid biopsy-based testing, especially using next-generation sequencing...
5 minute read
Copy That! Detecting Copy Number Variation in Disease Using Next Generation Sequencing
If one of your colleagues suggests including copy number variations (CNVs) in your assay that...
4 minute read
How to get the most from your Seraseq® FFPE Reference Materials
Most tumor profiling assay workflows use tissue biopsy samples that are formalin fixed and paraffin...
5 minute read
When a Bad Repair Leads to a Happy Ending: Homologous Recombination Deficiency Assays for Guiding Anti-Cancer Therapies
Genome instability - in which tumor cells sustain elevated frequencies of chromosomal lesions - is...
6 minute read
Optimal Reference Materials for Evolving Oncology Testing
Targeted therapies are dramatically improving cancer treatment. Next-generation sequencing (NGS)...
2 minute read
Are your BRCA1/2 tests sufficient?
Breast cancer susceptibility genes 1 and 2 (BRCA1 and BRCA2) encode proteins functioning as tumor...
4 minute read